Literature DB >> 6100001

Prevalence, clinical manifestations, and immunology of herpesvirus infections in the acquired immunodeficiency syndrome.

G V Quinnan, A H Rook, W R Frederick, J F Manischewitz, J S Epstein, J Siegel, H Masur, A M Macher, C Mitchell, G Armstrong.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6100001     DOI： 10.1111/j.1749-6632.1984.tb37138.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  7 in total

1.  Pathogenesis of Cryptococcus neoformans in congenitally immunodeficient beige athymic mice.

Authors:  C A Salkowski; E Balish
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

2.  Replication of cytomegalovirus in human thymic epithelial cells.

Authors:  K Numazaki; L DeStephano; I Wong; H Goldman; B Spira; M A Wainberg
Journal:  Med Microbiol Immunol       Date:  1989       Impact factor: 3.402

3.  Sera from patients with the acquired immunodeficiency syndrome inhibit production of interleukin-2 by normal lymphocytes.

Authors:  J P Siegel; J Y Djeu; N I Stocks; H Masur; E P Gelmann; G V Quinnan
Journal:  J Clin Invest       Date:  1985-06       Impact factor: 14.808

4.  Interleukin 2 therapy in infectious diseases: rationale and prospects.

Authors:  J P Siegel; A H Rook; J Y Djeu; G V Quinnan
Journal:  Infection       Date:  1984 Jul-Aug       Impact factor: 3.553

5.  Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines.

Authors:  L Buonaguro; G Barillari; H K Chang; C A Bohan; V Kao; R Morgan; R C Gallo; B Ensoli
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

6.  Detection of cytomegalovirus in bronchial lavage and urine using a monoclonal antibody to an HCMV early nuclear protein.

Authors:  C Schacherer; W Braun; G Bauer; H W Doerr
Journal:  Infection       Date:  1988 Sep-Oct       Impact factor: 3.553

7.  Interleukin 2 therapy in infectious diseases: rationale and prospects.

Authors:  J P Siegel; A H Rook; J Y Djeu; G V Quinnan
Journal:  Infection       Date:  1985       Impact factor: 3.553
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.